The impact of using reinforcement learning to personalize communication on medication adherence: findings from the REINFORCE trial
Lauffenburger JC, Yom-Tov E, Keller PA, McDonnell ME, Crum KL, Bhatkhande G, Sears ES, Hanken K, Bessette LG, Fontanet CP, Haff N, Vine S, Choudhry NK
NPJ Digit Med
2024 February 19
Reducing ethnic and racial disparities by improving undertreatment, control, and engagement in blood pressure management with health information technology (REDUCE-BP) hybrid effectiveness-implementation pragmatic trial: Rationale and design
Lauffenburger JC, Khatib R, Siddiqi A, Albert MA, Keller PA, Samal L, Glowacki N, Everett ME, Hanken K, Lee SG, Bhatkhande G, Haff N, Sears ES, Choudhry NK
Am Heart J
2023 January
REinforcement learning to improve non-adherence for diabetes treatments by Optimising Response and Customising Engagement (REINFORCE): study protocol of a pragmatic randomised trial
Lauffenburger LC, Yum-Tov E, Keller PA, McDonnell ME, Bessette LG, Fontanet CP, Sears ES, Kim E, Hanken K, Buckley JJ, Barlev RA, Haff N, Choudhry NK
BMJ Open
2021 December 3
Medication Adherence and Blood Pressure Control: A Scientific Statement From the American Heart Association
Choudhry NK, Kronish IM, Congpatanasin W, Ferdinand KC, Pavlik VN, Egan BM, Schoenthaler A, Houston Miller N, Hyman DJ; American Heart Association Council on Hypertension; Council on Cardiovascular and Stroke Nursing; and Council on Clinical Cardiology
Hypertension
2021 October 7
The accuracy of self-reported blood pressure in the Medication adherence Improvement Support App For Engagement - Blood Pressure (MedISAFE-BP) Trial: Implications for Pragmatic Trials.
Haff N, Lauffenburger JC, Morawski K, Ghazinouri R, Noor N, Kumar S, Juusola J, Choudhry NK.
Am Heart J
2020 February
Comparison of a new three-item self-reported measure of adherence to medication with pharmacy claims data in patients with cardiometabolic disease.
Lauffenburger JC, Fontanet CP, Isaac T, Gopalakrishnan C, Sequist TD, Gagne JJ, Jackevicius CA, Fischer MA, Solomon DH, Choudhry NK.
Am Heart J
2020 June
Effect of Targeted Insulin Adherence Interventions for Glycemic Control With Predictive Analytics Among Patients With Type 2 Diabetes: The TARGIT-Diabetes Randomized Clinical Trial.
Lauffenburger JC, Lewey J, Jan S, Makanji S, Ferro CA, Krumme AA, Lee J, Ghazinouri R, Haff N, Choudhry NK.
JAMA Network Open
2019 March 15
Effect of a Remotely Delivered Tailored Multicomponent Approach to Enhance Medication Taking for Patients With Hyperlipidemia, Hypertension, and Diabetes: The STIC2IT Cluster Randomized Clinical Trial.
Choudhry NK, Isaac T, Lauffenburger JC, Gopalakrishnan C, Lee M, Vachon A, Iliadis TL, Hollands W, Elman S, Kraft JM, Naseem S, Doheny S, Lee J, Barberio J, Patel L, Khan NF, Gagne JJ, Jackevicius CA, Fischer MA, Solomon DH, Sequist TD.
JAMA Internal Medicine
2018 September
Rationale and design of the Study of a Tele-pharmacy Intervention for Chronic diseases to Improve Treatment adherence (STIC2IT): A cluster-randomized pragmatic trial.
Choudhry NK, Isaac T, Lauffenburger JC, Gopalakrishnan C, Khan NF, Lee M, Vachon A, Iliadis TL, Hollands W, Doheny S, Elman S, Kraft JM, Naseem S, Gagne JJ, Jackevicius CA, Fischer MA, Solomon DH, Sequist TD.
Am Heart J
2016 October